Research Topics
| M F BrennanSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancerAbeezar I Sarela
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg Oncol 11:380-6. 2004..With accurate nodal staging, pN0 was associated with excellent prognosis. With pN+, prognosis was similar to that for gastric antral adenocarcinoma...
Knowledge helps, but alone it is not enoughMurray F Brennan
Ann Surg Oncol 15:1555-6. 2008
Pre-emptive surgery and increasing demands for technical perfectionMurray F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Br J Surg 90:3-4. 2003
Invited commentary: Surgery and chemotherapy for peritoneal carcinomatosis--more about selection and biology than treatment?Murray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Surgery 137:417-8. 2005
Soft tissue sarcoma: advances in understanding and managementM F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Surgeon 3:216-23. 2005..Identification of targeted therapy utilising direct specific molecular targets raises hope that future progress in control, if not cure, is realistic...
The international medical graduate in the US surgical training system: perspectives of an aging warriorMurray F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Surgery 140:362-6. 2006
Pancreatic cancerM F Brennan
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Gastroenterol Hepatol 15:G13-6. 2000..Advances in management are confined to more accurate preoperative diagnosis and staging, and decreased operative mortality. Long-term survival in the absence of resection remains poor...
Outcome--more than just operative mortalityMurray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Surg Oncol 99:470-7. 2009..More current studies now relate long term cancer survival to other issues of specialization, volume, payor and institution. The challenge is to determine what volume thresholds are sufficient for acceptable outcomes...
Lessons learnedMurray F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room H-1203, New York, NY 10021, USA
Ann Surg Oncol 13:1322-8. 2006
Randomized clinical trials in oncology commentaryMurray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Surg Oncol Clin N Am 11:1-2, vii. 2002..A brief description is given of three problems, which are how to bring the derived information into broad applicability, when are the results of a trial significant enough to make it a standard for care and the issue of quality control...
Lifelong surgical education: adapt, change, or witherMurray F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Arch Surg 142:394-8. 2007
Have you noticed?Murray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Institute, New York, NY, USA
Surgery 137:389-90. 2005
Adjuvant therapy following resection for pancreatic adenocarcinomaMurray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Surg Oncol Clin N Am 13:555-66, vii. 2004..At the current time, given the relative failure of standard adjuvant approaches, it is reasonable to suggest that all patients should have tissue harvested for molecular markers and enter into investigative regimens...
Safety in numbersM F Brennan
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Br J Surg 91:653-4. 2004
Surgical education in the United States: portents for changeMurray F Brennan
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg 240:565-72. 2004
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreasMurray F Brennan
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 240:293-8. 2004..Predictive nomograms are becoming increasingly used to define and predict outcome. They can be developed at presentation or following treatment and include variables not conventionally used in standard staging systems...
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable diseaseK A Bickenbach
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, USA
Ann Surg Oncol 19:1663-9. 2012..The objective of this study was to evaluate outcome of initially unresectable patients who respond to multimodality therapy and undergo resection...
Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatmentA Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Arch Surg 136:70-9. 2001..Complete surgical resection is the recommended treatment approach to achieve local control. Stratification by prognostic factors will facilitate selection of patients with STS for adjuvant systemic therapies...
Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomasC Cordon-Cardo
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021
Cancer Res 54:794-9. 1994..The overexpression of p53 and mdm2 proteins in the nuclei of tumor cells did not always correlate well with gene amplification at the mdm2 locus or mutation at the p53 gene. The possible reasons for these discrepancies are discussed...
Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumorsA Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer Res 61:3171-5. 2001..pRB and Ki-67 status may be useful to predict recurrence in certain subsets of patients...
Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over timeJurgen Weitz
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 21:2719-25. 2003..The objective of this study was to define whether survival of patients with extremity soft tissue sarcoma (STS), stratified for known risk factors, has improved over the last 20 years...
Effect of reresection in extremity soft tissue sarcomaJ J Lewis
Departments of Surgery, Biostatistics, and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 231:655-63. 2000..This study correlates reresection with local recurrence-free survival, metastasis-free survival, and disease-free survival...
Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremityJ J Lewis
Departments of Surgery, Biostatistics, and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 18:2087-94. 2000..The objective of this study was to determine independent prognostic factors of primary synovial sarcoma localized to the extremity...
Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumorsA Hoos
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Am J Pathol 158:1245-51. 2001..Concordance of triplicate cores is high (96 to 98%) for two category distinction and decreases with the complexity of the phenotypes being analyzed (91%)...
Clinicopathologic analysis of patients with adult rhabdomyosarcomaW G Hawkins
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer 91:794-803. 2001..All histologic subtypes of RMS are aggressive malignancies with poor disease specific survival despite aggressive multimodality management...
Impact of hospital volume on operative mortality for major cancer surgeryC B Begg
Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
JAMA 280:1747-51. 1998....
Is intra-abdominal drainage necessary after pancreaticoduodenectomy?M J Heslin
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Gastrointest Surg 2:373-8. 1998..Routine use of drains after pancreaticoduodenectomy may not be necessary and should be subjected to a randomized trial...
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancerJ L Dikken
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
Eur J Surg Oncol 38:319-25. 2012..The aim of the present study is to determine whether preoperative chemotherapy is associated with any difference in the number of LNs obtained from specimens of patients who underwent curative surgery for gastric adenocarcinoma...
Results of total pancreatectomy for adenocarcinoma of the pancreasH M Karpoff
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Arch Surg 136:44-7; discussion 48. 2001..In patients who require total pancreatectomy for ductal adenocarcinoma, the survival is so poor as to bring into question the value of the operation...
Liver resection for colorectal metastasesY Fong
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 15:938-46. 1997..The current study was performed to determine if liver resection for colorectal metastases is safe and effective and to evaluate predictors of outcome...
Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcomaJ J Lewis
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Arch Surg 134:190-4. 1999..The majority of survival studies in patients with extremity soft tissue sarcoma have focused on early recurrence and mortality. There are few data addressing long-term follow-up and survival...
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?John C Mansour
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:3412-8. 2007..After publication of the MAGIC trial results, preoperative chemotherapy is increasingly used to treat advanced gastric cancer before resection. Tools for measuring response must be assessed...
Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumorsNarasimhan P Agaram
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 13:170-81. 2007..Our goal was to investigate the spectrum of pathologic response and molecular alterations in a group of GIST patients, clinically defined as having imatinib-stable/imatinib-responsive lesions, who underwent surgical resection...
The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcomaFritz C Eilber
Departments of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Ann Surg 240:686-95; discussion 695-7. 2004..Treatment with IF should be considered in patients with high-risk primary extremity liposarcoma...
Gastric carcinomaM S Karpeh
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 5:650-6. 1998....
Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patientsM H Bilsky
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Neurosurgery 49:1277-86; discussion 1286-7. 2001..This study is a retrospective analysis of the long-term outcomes of patients who had operations for sarcomas of the spine using modern surgical approaches, intralesional resections, and spinal instrumentation...
Adult perineal sarcomasS R Grobmyer
Department of Surgery, Memorial-Sloan Kettering Cancer Center, New York, New York, USA
J Surg Oncol 77:101-4. 2001..CONCLUSIONS: Aggressive therapy and follow-up beginning with wide excision can be associated with long-term survival in adults with primary perineal sarcoma...
Vascular soft-tissue sarcomas. An analysis of tumor-related mortalityM S Karpeh
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021
Arch Surg 126:1474-81. 1991..The survival of these patients depends on complete surgical resection and is independent of individual histologic characteristics of the tumor...
Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to presentNicholas A Shorter
Department of Surgery and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
J Pediatr Surg 37:887-92. 2002..However, the risk of recurrence for pancreatoblastoma is high. The roles of chemotherapy and radiation remain undefined...
An evidence-based approach to the surgical management of resectable pancreatic adenocarcinomaAlexander Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 196:954-64. 2003..CONCLUSIONS: Surgical resection remains the only potentially curative therapy for adenocarcinoma of the pancreas. There is no clear indication as to a single preferable resection approach...
Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinomaJason S Gold
Department of Surgery, VA Boston Healthcare System Brigham and Women s Hospital, West Roxbury, Massachusetts, USA
Ann Surg Oncol 14:3159-67. 2007..We tested the utility of a nomogram created for determining disease-specific survival (DSS) after R0 resection of gastric cancer in estimating DSS for patients with resected duodenal cancer...
Treatment of retroperitoneal sarcomasStephen R Grobmyer
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Adv Surg 38:13-29. 2004
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunkKimberly Moore Dalal
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 244:381-91. 2006..DSS nomograms aid in more accurate counseling of patients, identification of patients appropriate for adjuvant therapy, and stratification of patients for clinical trials and molecular analysis...
Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experienceJ N Vauthey
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 2:126-31. 1995..Prior studies have shown a high rate of local recurrence and a dismal overall prognosis in malignant peripheral nerve sheath tumors (MPNSTs)...
Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremityK M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 48:1051-8. 2000..The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection...
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancerB Brenner
Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University of New York, New York 10021, USA
Ann Oncol 17:1404-11. 2006..p. FUdR/LV can be safely delivered to patients undergoing radical gastrectomy and D2 lymphadenectomy. The R0 resection and the survival rates are encouraging. An association between pathologic response and patient outcome was suggested...
Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomasM S Karpeh
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Br J Cancer 72:986-91. 1995..It is postulated that RB alterations are primary events in human sarcomas and may be involved in tumorigenesis or early phases of tumour progression in these neoplasias...
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinomaR C Fields
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Br J Cancer 104:1840-7. 2011..To characterise recurrence patterns and survival following pathologic complete response (pCR) in patients who received preoperative therapy for localised gastric or gastrooesophageal junction (GEJ) adenocarcinoma...
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resectionK C Conlon
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Ann Surg 234:487-93; discussion 493-4. 2001..Based on these results, closed suction drainage should not be considered mandatory or standard after pancreatic resection...
Soft tissue sarcomas of the groin: diagnosis, management, and prognosisA D Brooks
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 193:130-6. 2001..The biology of these tumors is similar to other extremity STS, and similar principles of management apply. Even with neurovascular involvement, most patients with primary groin STS do not require amputation...
Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparisonB M Clary
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 8:290-9. 2001..The pattern of distant spread follows the known patterns of hematogenous dissemination. Complete surgical resection is the cornerstone of treatment for primary GIST and LMS and in selected patients with local and distant recurrence...
Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcomeA Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 8:509-18. 2001..Amputation improves local disease control but not survival under these circumstances...
Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity?Jonathan B Koea
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 10:432-40. 2003..We attempted to define the effect of tumor histotype on local recurrence, distant metastasis, and disease-specific survival in patients with surgically treated primary extremity sarcoma...
Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinomaAbeezar I Sarela
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 10:783-91. 2003..44%). pN2 or pN3 were mainly limited to SS tumors and these patients had poor survival (26% and 0%). CONCLUSION: For pT2 gastric adenocarcinoma, the depth of mural invasion was not an independently significant prognostic factor...
Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?Margo Shoup
From the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Gastrointest Surg 8:1068-71. 2004..Patients considered for treatment protocols for locally unresectable pancreatic cancer should be staged laparoscopically before initiation of therapy...
Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?Rebecca A Gladdy
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 1209, New York, NY 10065, USA
J Clin Oncol 28:2064-9. 2010..DSS in patients with primary RAS is significantly worse compared with sporadic STS independent of sarcoma histologic type...
Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapyOren Cahlon
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 112:2774-9. 2008....
Long-term results with resection of radiation-induced soft tissue sarcomasCharles Cha
Surgical Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg 239:903-9; discussion 909-10. 2004..Surgical resection remains the primary therapy, but 5-year survival remains approximately 40%...
Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumorRonald P Dematteo
Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Curr Probl Surg 40:144-93. 2003
Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groupsSteven N Hochwald
Department of Surgery, University of Florida College of Medicine, Gainesville, FL, USA
J Clin Oncol 20:2633-42. 2002..An alternative system based on mitotic rate and necrosis correlates strongly with survival without specifically designating any group as benign...
Current status of surgery for gastric cancer: a reviewMurray F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Gastric Cancer 8:64-70. 2005..The international gastric cancer community can help define the important issues that need to be answered in the coming decades...
Why do patients with low-grade soft tissue sarcoma die?Robert J Canter
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg Oncol 15:3550-60. 2008..The patterns of failure and mechanisms of sarcoma-specific death are poorly characterized among the minority of patients with low-grade soft tissue sarcoma (STS) who succumb to disease...
Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinomaAbeezar I Sarela
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 243:189-95. 2006..Intervention-related mortality was minimal. The burden of metastatic disease and functional performance status were important prognostic factors...
Results of hepatic resection for sarcoma metastatic to liverR P DeMatteo
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg 234:540-7; discussion 547-8. 2001..Hepatectomy should be considered when complete gross resection is possible, especially when the time to the development of liver metastasis exceeds 2 years...
The clinical approach to desmoplastic small round cell tumorM P Quaglia
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Surg Oncol 9:77-81. 2000..Conclusion: We recommend induction chemotherapy (P6) followed by aggressive surgical debulking and external beam radiotherapy for the treatment of DSRCT. Further progress will require new forms of treatment...
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomyS P Povoski
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Gastrointest Surg 3:496-505. 1999..These data suggest that preoperative biliary drainage should be avoided in candidates for pancreaticoduodenectomy...
Hürthle cell carcinoma: a critical histopathologic appraisalA Stojadinovic
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:2616-25. 2001..Unlike differentiated thyroid cancer, nodal metastases predict a worse outcome in widely invasive Hürthle cell carcinoma, as does extrathyroidal extension...
Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal modelW R Jarnagin
Departments of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 231:762-71. 2000..To evaluate the neoadjuvant use of a herpes simplex viral (HSV) amplicon vector expressing the murine interleukin-12 (IL-12) gene...
Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?Margo Shoup
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Gastrointest Surg 7:946-52; discussion 952. 2003..Extended distal pancreatectomy is justified in this group of patients...
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogramRebekah R White
Department of Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA
Ann Surg Oncol 13:1485-92. 2006..The ability of the nomogram to evaluate the effects of preop CRT on survival is limited by the potential effects of preop CRT on factors within the nomogram...
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinomaMichael W Kattan
Department of Urology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, C1275 New York, NY 10021, USA
J Clin Oncol 21:3647-50. 2003..This tool should be useful for patient counseling, follow-up scheduling, and clinical trial eligibility determination...
Outcome of metastatic GIST in the era before tyrosine kinase inhibitorsJason S Gold
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 14:134-42. 2007..Treatment of metastatic GIST with imatinib mesylate results in a 2-year survival of approximately 72%. The outcome of patients with metastatic GIST not treated with tyrosine kinase inhibitors is not well defined...
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogramVivian E Strong
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg 251:640-6. 2010..To compare disease-specific survival (DSS) between the US and Korea following R0 resection for gastric carcinoma (GC)...
Extended local resection for advanced gastric cancer: increased survival versus increased morbidityRobert C G Martin
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Surg 236:159-65. 2002..Additional organ resection can be performed with minimal morbidity and can improve the chance of overall survival in patients with advanced T-stage disease...
Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month ruleJames O Park
Soft Tissue Sarcoma Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 250:977-82. 2009..To identify the prognostic variables that predict disease-specific survival and second local recurrence-free survival in patients with recurrent retroperitoneal liposarcoma so as to guide clinical management...
The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinomaCristina R Ferrone
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Gastrointest Surg 10:1347-53. 2006..23% negative; P=0.006). In this study, patients who underwent resection in the presence of positive peritoneal cytology and absence of other identifiable metastatic disease had a similar survival as other patients with stage IV disease...
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinomaShishir K Maithel
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg Oncol 15:3512-20. 2008..Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined...
Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumorsA D Brooks
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 8:92-100. 2001..Intraoperative FS added very little to surgical management. The majority of thyroid operations at this institution are planned and performed based on known prognostic factors and intraoperative findings...
Laparoscopy predicts metastatic disease and spares laparotomy in selected patients with pancreatic nonfunctioning islet cell tumorsS N Hochwald
Department of Surgery, University of Florida College of Medicine, Gainesville, USA
Ann Surg Oncol 8:249-53. 2001..Despite metastatic disease, prolonged survival is often achieved with or without open surgical treatment. Laparoscopy can be used in diagnosis and accurately identifies metastases not seen on CT, thus sparing laparotomy in some patients...
High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomasA Hoos
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer 92:869-74. 2001....
Surgical oncology fellowship: viable pathway to academic surgery?M J Heslin
Department of Surgery Memorial Sloan Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 6:542-5. 1999..Data that document academic status after surgical oncology fellowship are sparse. This study was done to report the academic status and clinical practice of graduates of a major surgical oncology program...
Post-treatment sarcoma in breast cancer patientsM S Brady
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021
Ann Surg Oncol 1:66-72. 1994..Many patients treated for breast cancer with radiotherapy will survive their disease and be at risk for treatment-related sarcoma for many years...
Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunkK M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 47:1273-9. 2000..The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage...
Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcomaMario M Leitao
Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Gynecol Oncol 87:287-94. 2002..Time to first recurrence and optimal surgical resection were predictors of improved outcome in this study...
Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thighAndreas Rimner
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Cancer 115:149-57. 2009..The authors sought to determine whether differences existed in patterns of outcome and morbidity between the 3 thigh compartments after limb-sparing surgery and postoperative radiation therapy (RT)...
Neoadjuvant therapy for gastric cancerMichael G House
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Adv Surg 42:151-68. 2008..Patients who are determined to have high-risk disease postoperatively should be offered adjuvant therapy that will address the site of recurrence most likely to affect survival...
Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysisRobert J Canter
Division of Surgical Oncology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 110:2050-60. 2007..To the authors' knowledge, few studies to date have examined the effect of chemotherapy in patients undergoing pulmonary resection for metastatic STS of the extremity...
The role of pulmonary metastasectomy in soft tissue sarcomaLarissa K F Temple
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Semin Thorac Cardiovasc Surg 14:35-44. 2002..Future research is needed to better identify patients for metastasectomy, to determine the role of minimally invasive procedures, and to develop better adjuvant therapy...
Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasmsKevin K Roggin
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 12:971-80. 2005..Conversion to PD should be considered when intraoperative or final pathology identifies invasive adenocarcinoma. Refinement of clinicopathologic factors may reduce the occasional PD for benign disease and AMP for malignancy...
Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcomeAndrew P Barbour
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Ann Surg Oncol 14:306-16. 2007..The aim of this study was to determine whether adequate staging revealed different prognostic factors or improved survival compared with patients with <15 nodes examined after R0 resection for GEJ cancer...
Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junctionAndrew P Barbour
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 205:593-601. 2007..The purpose of this study was to compare preoperative EUS staging with postoperative pathologic staging and to assess the ability of EUS to predict survival after resection for GEJ adenocarcinoma...
Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?Robert C G Martin
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 194:568-77. 2002..Given the potential for increased morbidity and mortality from multiple organ resection we asked the question as to whether extended (multiple organ) resection was justified for advanced gastric cancer...
The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumorsAri D Brooks
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Gastrointest Surg 6:139-45; discussion 145-6. 2002..We believe that laparoscopy should be used in a selective manner for preoperative staging of patients suspected of having nonpancreatic periampullary tumors...
Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patientsN Volkan Adsay
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 1002, USA
Cancer 94:62-77. 2002....
Adult spermatic cord sarcomas: management and resultsJonathan Coleman
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg Oncol 10:669-75. 2003..CONCLUSIONS: We demonstrated that aggressive surgical strategies, including reoperative wide resection, significantly decrease local recurrence and may improve disease free-survival in select patients with spermatic cord sarcoma...
Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?Hong Jin Kim
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Gastrointest Surg 6:763-9. 2002..Novel multimodality approaches are required...
Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancerJurgen Weitz
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Clin Oncol 21:4597-603. 2003....
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institutionMichael G House
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Am Coll Surg 210:744-52, 752-5. 2010..This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time...
Adequate lymph node assessment for extrahepatic bile duct adenocarcinomaKaori Ito
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Ann Surg 251:675-81. 2010..To examine the importance of adequate lymph node sampling in staging of extrahepatic bile duct cancer (EHBDCA)...
Predictive variables detailing the recurrence rate of soft tissue sarcomasStephen R Grobmyer
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Opin Oncol 15:319-26. 2003..Emerging areas in predicting outcome of patients with soft tissue sarcoma include response to neoadjuvant chemotherapy and molecular markers...
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 casesC R Antonescu
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 7:3977-87. 2001..We also analyzed P53 status, because this parameter has been found to have a significant prognostic impact in other sarcomas with chromosomal translocations...
